SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VVUS: VIVUS INC. (NASDAQ)
An SI Board Since September 1997
Posts SubjectMarks Bans Symbol
23519 69 0 VVUS
Emcee:  Frostman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
23469Looks like VVUS and First Manhattan are coming to an agreement, finally. VVUS iBiotech Jim-7/18/2013
23468delayed the vote; offer a couple seats; whine to the SEC... what next??mopgcw-7/15/2013
23467and the proxy fight begins...mopgcw-6/4/2013
234661st Manhattan disclosed that it owns 9.9% after buying more for $12.50 to $13.48mopgcw-6/3/2013
23465Director buys a decent chunk here...mopgcw-5/30/2013
23464WHY O WHY a convert??? argh.mopgcw-5/16/2013
23463I added another couple slugs when she hit 10 and change again. getting heavy. mopgcw-4/19/2013
23462Qsymia prescriptions shipped Month Ended January 31, 2013 16,733 Month Ended FBiotech Jim-4/19/2013
23461VIVUS, Inc. (Nasdaq: VVUS) announced that the U.S. Food and Drug AdministrationThe Ox-4/18/2013
23460VIVUS, Inc. (NASDAQ: VVUS) 5% LOWER; announced today that the European Medicinesmopgcw-2/22/2013
23459Leerink Swann Resumes Vivus (VVUS) at Outperform, $19-$20 Valuation 7:17 AM 2/mopgcw-2/6/2013
23458VIVUS, Inc. (VVUS) Qsymia Prescriptions Show Gains During Slow Holiday Week (ARNmopgcw-2/4/2013
23457Vivus rises on latest Qsymia prescription report 3:23 PM 1/7/2013 - AcquireMedmopgcw-1/7/2013
23456From ML/BAC <i> Vivus (VVUS) has been added to the US 1 list today. Todatom pope-1/7/2013
23455<i>Vivus Inc. (VVUS). The company said its obesity drug will now be coveretom pope-12/20/2012
23454Best analysis I’ve seen of Qsymia dilemma: siliconinvestor.com :-)DewDiligence_on_SI-11/6/2012
23453Amazed that VVUS has dropped this low, but I decided to pick up a pudgy amount oBiotech Jim-11/6/2012
23452VIVUS (VVUS) Sinks on Conference Call; 30% of Qsymia Scipts Abandoned Due to Casmopgcw-11/6/2012
23451Latest Qsymia Data Shaping Up to Potential Bear Case for VIVUS (VVUS) and Peers mopgcw-10/31/2012
23450The EU also feels burned by Mediator, the product of a private French company - Biotech Jim-10/22/2012
23449Didn't verify such, but today's Acquire Media report indicated that presscaram(o)uche-10/22/2012
23448<i> Shares of Vivus Inc. fell after an analyst said Wall Street may be ovtom pope-10/18/2012
23447Don't own any VVUS,but the big drop caught my eye. SA <i> Vivus ( VVtom pope-9/21/2012
23446Chromadex’ pterostilbene human clinical study results are due to be released on Kelly Alberto-9/13/2012
23445As vivus offers this type treatment where ChromaDex taken a whole market businesshohelkhan-9/7/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News